A detailed history of Handelsbanken Fonder Ab transactions in Enovis Corp stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 13,317 shares of ENOV stock, worth $582,086. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,317
Previous 10,517 26.62%
Holding current value
$582,086
Previous $453,000 28.92%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025

BUY
$38.5 - $49.33 $107,800 - $138,124
2,800 Added 26.62%
13,317 $584,000
Q3 2024

Oct 04, 2024

BUY
$40.57 - $48.1 $105,482 - $125,060
2,600 Added 32.84%
10,517 $453,000
Q2 2024

Aug 05, 2024

BUY
$44.56 - $62.43 $35,648 - $49,944
800 Added 11.24%
7,917 $358,000
Q2 2022

Aug 03, 2022

BUY
$55.0 - $70.47 $391,435 - $501,534
7,117 New
7,117 $391,000

Others Institutions Holding ENOV

About Enovis CORP


  • Ticker ENOV
  • Exchange NYSE
  • Sector Industrials
  • Industry Specialty Industrial Machinery
  • Shares Outstandng 54,129,500
  • Market Cap $2.37B
  • Description
  • Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...
More about ENOV
Track This Portfolio

Track Handelsbanken Fonder Ab Portfolio

Follow Handelsbanken Fonder Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.